River Park Advisors, LLC Bristol Myers Squibb CO Transaction History

River Park Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $1.6 Million - $1.8 Million	-26,941 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $209,307 - $237,183	-3,625 Reduced 11.86%	26,941 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $162,871 - $180,483	2,836 Added 10.23%	30,566 $1.84 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $16,226 - $18,970	296 Added 1.08%	27,730 $1.63 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $781,840 - $1.14 Million	-16,850 Reduced 38.05%	27,434 $1.53 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $2.18 Million - $2.84 Million	44,284 New	44,284 $2.84 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on River Park Advisors, LLC with notifications on news.